Derived From Leafy Green Plants, E.g., Alfalfa Pollen, Etc. Patents (Class 530/379)
  • Patent number: 5149528
    Abstract: Purified cytotoxic proteins for use within therapeutic compositions are disclosed. The proteins inhibit protein synthesis in vitro, exhibit abortifacient activity in mice, and contain proline residues with equivalent positions at residue 43 and residue 46 in ricin A-chain. A method for preparing such a cytotoxic protein from the tissue of Trichosanthes kirilowii is also disclosed. The proteins may also be used within a method for inhibiting protein synthesis in selected cells.
    Type: Grant
    Filed: November 13, 1989
    Date of Patent: September 22, 1992
    Assignee: ZymoGenetics, Inc.
    Inventors: John M. Maraganore, Wayne R. Kindsvogel
  • Patent number: 5073628
    Abstract: A novel hyposensitization agent was prepared by covalently attaching a saccharide to a cedar pollen allergen having a partial amino acid sequence of Ala-Ile-Asn-Ile-Phe-Asn- beginning at its N-terminal. The hyposensitization agent, when compared with an intact cedar pollen allergen, extremely accelerates the production of immunoglobulin G and M antibodies which are specific to intact cedar pollen allergen, but extremely reduces the production of immunoglobulin E antibody which is specific to the allergen. Thus, the hyposensitization agent is administrable to cedar pollinosis patients with no anaphylaxis and allergy, and cuts hyposensitization period to about 1/3 to 1/200.
    Type: Grant
    Filed: August 29, 1990
    Date of Patent: December 17, 1991
    Assignee: Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Tyoku Matsuhashi, Mitsuko Usui, Masakazu Mitsuhashi, Shunsaku Ando
  • Patent number: 5037960
    Abstract: The present invention relates to a novel glycoprotein, extracted from the seeds of Trichosanthes kirilowii, called: trichokirin, as well as to its modified derivatives containing a free or blocked SH group.It relates to a process for its preparation, to its use and to pharmaceutical compositions in which it is present.
    Type: Grant
    Filed: July 14, 1987
    Date of Patent: August 6, 1991
    Assignee: Sanofi
    Inventors: Luigi Barbieri, Pierre Casellas, Fiorenzo Stirpe
  • Patent number: 5037959
    Abstract: A class of proteins associated with self-incompatibility alleles of plants, preferably of gametophytic self-incompatibility type, are provided. These proteins inhibit pollen tube growth in a plant style having the associated self-incompatibility allele, and have defined amino acid homologies and cross-reactivities.
    Type: Grant
    Filed: May 15, 1987
    Date of Patent: August 6, 1991
    Assignee: Lubrizol Genetics, Inc.
    Inventors: Adrienne E. Clarke, Elizabeth G. Williams, Marilyn A. Anderson, Shaio-Lim Mau, Rosslyn Hoggart, Edwina Cornish
  • Patent number: 4985541
    Abstract: Purified cytotoxic proteins for use within therapeutic compositions are disclosed. The proteins inhibit protein synthesis in vitro, exhibit abortifacient activity in mice, and contain proline residues with equivalent positions at residue 43 and residue 46 in ricin A-chain. A method for preparing such a cytotoxic protein from the tissue of Trichosanthes kirilowii is also disclosed. The proteins may also be used within a method for inhibiting protein synthesis in selected cells.
    Type: Grant
    Filed: April 10, 1987
    Date of Patent: January 15, 1991
    Assignee: ZymoGenetics, Inc.
    Inventors: John M. Maraganore, Wayne R. Kindsvogel
  • Patent number: 4939239
    Abstract: A novel hyposensitization agent was prepared by covalently attaching a saccharide, e.g. homo- and heteroglycans, for example, starch, amylose, dextran, polysucrose, pullulan, elsinan, curdlan, gum arabic, gum tragacanth, guar gum, xanthan gum carrageenan, pectin, cellulose, glucomannan, chitosan, and lipopolysaccharide, and their derivatives and partial hydrolysates to, a cedar pollen allergen. The hyposensitization agent can be administered to a cedar pollinosis patient without fear of eliciting anaphylaxis and allergy within a shortened hyposensitization period because the hyposensitization agent much more enhances the production of immunoglobulin G and M antibodies which are specific to intact cedar pollen allergen, but extremely reduces the production of immunoglobulin E antibody which is specific to the allergen and responsible for anaphylaxis and allergy.
    Type: Grant
    Filed: September 1, 1988
    Date of Patent: July 3, 1990
    Assignee: Kabushiki Kaisha Hayashibara Seitbutsu Kangaku/Kenkyujo
    Inventors: Tyoku Matsuhashi, Mitsuko Usui, Masakazu Mitsuhashi, Shunsaku Ando
  • Patent number: 4877738
    Abstract: The invention includes substantially pure cultures of ATCC 53522 and mutants thereof effective in protecting plants from damping off the root rot as determinable by a defined plant protection assay. The invention further includes a protecting toxin produced by the bacteria just referred to. A seed inoculum includes an effective quantity of the bacteria or the toxin in a carrier. A method for protecting plants from damping off and root rot includes placing an effective quantity of the bacteria or toxin in the immediate vicinity of a plant to be protected.
    Type: Grant
    Filed: July 25, 1986
    Date of Patent: October 31, 1989
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Jo Handelsman, Ellen H. Mester, Lynn Wunderlich
  • Patent number: 4855284
    Abstract: New calcium and magnesium complexes of phytohemagglutinin-polyheteroglycans are distinguished inter alia by cytoprotective, antiinflammatory and immunostimulating properties. They have characteristic molecular weights and distribution thereof, infrared spectra and compositions in respect of calcium and/or magnesium, phosphorus, glycans and amino acids. The preparation is carried out by extraction of the phytohemagglutinin-polyglycans with water of weakly alkaline pH from plants, in particular of the families Compositae, Malvaceae, Cucurbitaceae and Gramineae, and precipitation with an alcohol which is miscible with water. The complexes can be used for the treatment of ulcers, inflammations or viral infections, or as immunostimulant.
    Type: Grant
    Filed: August 18, 1986
    Date of Patent: August 8, 1989
    Assignee: Intex Pharmazeutische Produkte AG
    Inventor: Gabriel Emoedi
  • Patent number: 4588691
    Abstract: An improved method for the purification of ribulose, 1,5-bisphosphate carboxylase (RuBisCO) comprises comminuting and homogenizing a plant material, such as leaves, in an aqueous solution. After fractionation to release the RuBisCO, sufficient polyethylene glycol (PEG) is added to cause crystallization of the RuBisCO. It has been found that treatment of the resulting PEG supernatant first by acidification to remove other proteins, and then by addition of a strong base to remove phosphorylated sugars, allows the recycling of the PEG in the process. Moreover, it is found that the phosphorylated sugars are a valuable by-product, suitable for example as a carbon source for the culture of microorganisms.
    Type: Grant
    Filed: February 29, 1984
    Date of Patent: May 13, 1986
    Inventor: Sarjit S. Johal